mRNA |
BMS-754807 |
GDSC1000 |
pan-cancer |
AAC |
0.064 |
0.07 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.07 |
mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
0.092 |
0.07 |
mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.07 |
mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.07 |
mRNA |
SB590885 |
GDSC1000 |
pan-cancer |
AAC |
-0.061 |
0.07 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.07 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.07 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.07 |
mRNA |
S-Trityl-L-cysteine |
FIMM |
pan-cancer |
AAC |
-0.31 |
0.07 |